US Patent 10640800 Mice that produce hybrid antibodies
Patent 10640800 was granted and assigned to Regeneron Pharmaceuticals on May, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106408000
Date of Patent
May 5, 2020
0Patent Application Number
152139470
Date Filed
July 19, 2016
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10640800 Mice that produce hybrid antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10640800
Date of patent
May 5, 2020
Patent application number
15213947
Date Filed
July 19, 2016
Patent primary examiner
Find more entities like US Patent 10640800 Mice that produce hybrid antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.